Gut Microbiota-Induced Immunoglobulin G Controls Systemic Infection by Symbiotic Bacteria and Pathogens

Immunity

Volumn 44, Issue 3, 2016, Pages 647-658

  Zeng, Melody Y ^a   Cisalpino, Daniel ^a,b   Varadarajan, Saranyaraajan ^a   Hellman, Judith ^c   Warren, H Shaw ^d   Cascalho, Marilia ^a   Inohara, Naohiro ^a   Núñez, Gabriel ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; IMMUNOGLOBULIN G; OUTER MEMBRANE PROTEIN; PEPTIDOGLYCAN; TOLL LIKE RECEPTOR 4; TLR2 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 2;

ARTICLE; B LYMPHOCYTE; BACTERIAL INFECTION; CONTROLLED STUDY; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; INTESTINE FLORA; MICROFLORA; NONHUMAN; PATHOGENESIS; PHAGOCYTE; PRIORITY JOURNAL; SALMONELLA; SALMONELLOSIS; SYSTEMIC DISEASE; T LYMPHOCYTE; ANIMAL; BACTERIAL LOAD; C57BL MOUSE; GENETICS; GRAM NEGATIVE INFECTION; HOMEOSTASIS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INTESTINE; KNOCKOUT MOUSE; METABOLISM; MICROBIOLOGY; MOUSE;

ANIMALS; BACTERIAL LOAD; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOMEOSTASIS; HOST-PATHOGEN INTERACTIONS; IMMUNOGLOBULIN G; INTESTINES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROBIOTA; PEPTIDOGLYCAN; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84960388607     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2016.02.006     Document Type: Article

References (49)

1. Alejandria M.M., Lansang M.A., Dans L.F., Mantaring J.B. Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock. Cochrane Database Syst. Rev. 2013, 9:CD001090.
2. Almansa R., Tamayo E., Andaluz-Ojeda D., Nogales L., Blanco J., Eiros J.M., Gomez-Herreras J.I., Bermejo-Martin J.F. The original sins of clinical trials with intravenous immunoglobulins in sepsis. Crit. Care 2015, 19:90.
3. Alverdy J.C., Chang E.B. The re-emerging role of the intestinal microflora in critical illness and inflammation: why the gut hypothesis of sepsis syndrome will not go away. J. Leukoc. Biol. 2008, 83:461-466.
4. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 2001, 29:1303-1310.
5. Barnich N., Carvalho F.A., Glasser A.L., Darcha C., Jantscheff P., Allez M., Peeters H., Bommelaer G., Desreumaux P., Colombel J.F., Darfeuille-Michaud A. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J. Clin. Invest. 2007, 117:1566-1574.
6. Bekeredjian-Ding I., Jego G. Toll-like receptors--sentries in the B-cell response. Immunology 2009, 128:311-323.
7. Benckert J., Schmolka N., Kreschel C., Zoller M.J., Sturm A., Wiedenmann B., Wardemann H. The majority of intestinal IgA+ and IgG+ plasmablasts in the human gut are antigen-specific. J. Clin. Invest. 2011, 121:1946-1955.
8. Caramalho I., Lopes-Carvalho T., Ostler D., Zelenay S., Haury M., Demengeot J. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 2003, 197:403-411.
9. Cascalho M., Ma A., Lee S., Masat L., Wabl M. A quasi-monoclonal mouse. Science 1996, 272:1649-1652.
10. Cascalho M., Wong J., Wabl M. VH gene replacement in hyperselected B cells of the quasimonoclonal mouse. J. Immunol. 1997, 159:5795-5801.
11. Cerutti A., Cols M., Puga I. Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes. Nat. Rev. Immunol. 2013, 13:118-132.
12. Chow J., Tang H., Mazmanian S.K. Pathobionts of the gastrointestinal microbiota and inflammatory disease. Curr. Opin. Immunol. 2011, 23:473-480.
13. Clark M.A., Hirst B.H., Jepson M.A. M-cell surface beta1 integrin expression and invasin-mediated targeting of Yersinia pseudotuberculosis to mouse Peyer's patch M cells. Infect. Immun. 1998, 66:1237-1243.
14. Geuking M.B., McCoy K.D., Macpherson A.J. The function of secretory IgA in the context of the intestinal continuum of adaptive immune responses in host-microbial mutualism. Semin. Immunol. 2012, 24:36-42.
15. Haas A., Zimmermann K., Graw F., Slack E., Rusert P., Ledergerber B., Bossart W., Weber R., Thurnheer M.C., Battegay M., et al. Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection. Gut 2011, 60:1506-1519. Swiss HIV Cohort Study.
16. Harmsen H.J., Pouwels S.D., Funke A., Bos N.A., Dijkstra G. Crohn's disease patients have more IgG-binding fecal bacteria than controls. Clin. Vaccine Immunol. 2012, 19:515-521.
17. Hasegawa M., Yada S., Liu M.Z., Kamada N., Muñoz-Planillo R., Do N., Núñez G., Inohara N. Interleukin-22 regulates the complement system to promote resistance against pathobionts after pathogen-induced intestinal damage. Immunity 2014, 41:620-632.
18. Hellman J., Warren H.S. Outer membrane protein A (OmpA), peptidoglycan-associated lipoprotein (PAL), and murein lipoprotein (MLP) are released in experimental Gram-negative sepsis. J. Endotoxin Res. 2001, 7:69-72.
19. Hellman J., Loiselle P.M., Tehan M.M., Allaire J.E., Boyle L.A., Kurnick J.T., Andrews D.M., Sik Kim K., Warren H.S. Outer membrane protein A, peptidoglycan-associated lipoprotein, and murein lipoprotein are released by Escherichia coli bacteria into serum. Infect. Immun. 2000, 68:2566-2572.
20. Hofer U., Schlaepfer E., Baenziger S., Nischang M., Regenass S., Schwendener R., Kempf W., Nadal D., Speck R.F. Inadequate clearance of translocated bacterial products in HIV-infected humanized mice. PLoS Pathog. 2010, 6:e1000867.
21. Kamada N., Chen G.Y., Inohara N., Núñez G. Control of pathogens and pathobionts by the gut microbiota. Nat. Immunol. 2013, 14:685-690.
22. Kamada N., Seo S.U., Chen G.Y., Núñez G. Role of the gut microbiota in immunity and inflammatory disease. Nat. Rev. Immunol. 2013, 13:321-335.
23. Kang C.I., Kim S.H., Park W.B., Lee K.D., Kim H.B., Kim E.C., Oh M.D., Choe K.W. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy. Antimicrob. Agents Chemother. 2004, 48:4574-4581.
24. Kirkland D., Benson A., Mirpuri J., Pifer R., Hou B., DeFranco A.L., Yarovinsky F. B cell-intrinsic MyD88 signaling prevents the lethal dissemination of commensal bacteria during colonic damage. Immunity 2012, 36:228-238.
25. Kubinak J.L., Round J.L. Toll-like receptors promote mutually beneficial commensal-host interactions. PLoS Pathog. 2012, 8:e1002785.
26. Lelouard H., Fallet M., de Bovis B., Méresse S., Gorvel J.P. Peyer's patch dendritic cells sample antigens by extending dendrites through M cell-specific transcellular pores. Gastroenterology 2012, 142:592-601.e3.
27. Liang M.D., Bagchi A., Warren H.S., Tehan M.M., Trigilio J.A., Beasley-Topliffe L.K., Tesini B.L., Lazzaroni J.C., Fenton M.J., Hellman J. Bacterial peptidoglycan-associated lipoprotein: a naturally occurring toll-like receptor 2 agonist that is shed into serum and has synergy with lipopolysaccharide. J. Infect. Dis. 2005, 191:939-948.
28. MacFie J. Current status of bacterial translocation as a cause of surgical sepsis. Br. Med. Bull. 2004, 71:1-11.
29. Macpherson A.J., McCoy K.D. Stratification and compartmentalisation of immunoglobulin responses to commensal intestinal microbes. Semin. Immunol. 2013, 25:358-363.
30. Macpherson A.J., Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004, 303:1662-1665.
31. Macpherson A.J., Gatto D., Sainsbury E., Harriman G.R., Hengartner H., Zinkernagel R.M. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 2000, 288:2222-2226.
32. Macpherson A.J., Geuking M.B., Slack E., Hapfelmeier S., McCoy K.D. The habitat, double life, citizenship, and forgetfulness of IgA. Immunol. Rev. 2012, 245:132-146.
33. Madan J.C., Salari R.C., Saxena D., Davidson L., O'Toole G.A., Moore J.H., Sogin M.L., Foster J.A., Edwards W.H., Palumbo P., Hibberd P.L. Gut microbial colonisation in premature neonates predicts neonatal sepsis. Arch. Dis. Child. Fetal Neonatal Ed. 2012, 97:F456-F462.
34. Mantis N.J., Rol N., Corthésy B. Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol. 2011, 4:603-611.
35. Mohammed N., Tang L., Jahangiri A., de Villiers W., Eckhardt E. Elevated IgG levels against specific bacterial antigens in obese patients with diabetes and in mice with diet-induced obesity and glucose intolerance. Metabolism 2012, 61:1211-1214.
36. Panda S., Zhang J., Tan N.S., Ho B., Ding J.L. Natural IgG antibodies provide innate protection against ficolin-opsonized bacteria. EMBO J. 2013, 32:2905-2919.
37. Peterson D.A., McNulty N.P., Guruge J.L., Gordon J.I. IgA response to symbiotic bacteria as a mediator of gut homeostasis. Cell Host Microbe 2007, 2:328-339.
38. Puga I., Cerutti A. Protection by natural IgG: a sweet partnership with soluble lectins does the trick!. EMBO J. 2013, 32:2897-2899.
39. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004, 118:229-241.
40. Rawlings D.J., Schwartz M.A., Jackson S.W., Meyer-Bahlburg A. Integration of B cell responses through Toll-like receptors and antigen receptors. Nat. Rev. Immunol. 2012, 12:282-294.
41. Rescigno M., Urbano M., Valzasina B., Francolini M., Rotta G., Bonasio R., Granucci F., Kraehenbuhl J.P., Ricciardi-Castagnoli P. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2001, 2:361-367.
42. Rodríguez J.M., Murphy K., Stanton C., Ross R.P., Kober O.I., Juge N., Avershina E., Rudi K., Narbad A., Jenmalm M.C., et al. The composition of the gut microbiota throughout life, with an emphasis on early life. Microb. Ecol. Health Dis. 2015, 26:26050.
43. Sedman P.C., Macfie J., Sagar P., Mitchell C.J., May J., Mancey-Jones B., Johnstone D. The prevalence of gut translocation in humans. Gastroenterology 1994, 107:643-649.
44. Shankar-Hari M., Spencer J., Sewell W.A., Rowan K.M., Singer M. Bench-to-bedside review: Immunoglobulin therapy for sepsis - biological plausibility from a critical care perspective. Crit. Care 2012, 16:206.
45. Shin H.S., Xu F., Bagchi A., Herrup E., Prakash A., Valentine C., Kulkarni H., Wilhelmsen K., Warren S., Hellman J. Bacterial lipoprotein TLR2 agonists broadly modulate endothelial function and coagulation pathways in vitro and in vivo. J. Immunol. 2011, 186:1119-1130.
46. Suzuki H., Nishimura Y., Yasuda S., Nishimura A., Yamada M., Hirota Y. Murein-lipoprotein of Escherichia coli: a protein involved in the stabilization of bacterial cell envelope. Mol. Gen. Genet. 1978, 167:1-9.
47. Suzuki K., Meek B., Doi Y., Muramatsu M., Chiba T., Honjo T., Fagarasan S. Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut. Proc. Natl. Acad. Sci. USA 2004, 101:1981-1986.
48. Thoene-Reineke C., Fischer A., Friese C., Briesemeister D., Göbel U.B., Kammertoens T., Bereswill S., Heimesaat M.M. Composition of intestinal microbiota in immune-deficient mice kept in three different housing conditions. PLoS ONE 2014, 9:e113406.
49. Wei M., Shinkura R., Doi Y., Maruya M., Fagarasan S., Honjo T. Mice carrying a knock-in mutation of Aicda resulting in a defect in somatic hypermutation have impaired gut homeostasis and compromised mucosal defense. Nat. Immunol. 2011, 12:264-270.